Home » Topics » Regulatory

Regulatory
RSS

First marketing approval for Novartis transplant drug

April 22, 1998

FDA clears new indication for Prevacid

April 17, 1998

Cosopt receives marketing approval from FDA

April 16, 1998

Antiviral drugs advisory committee will discuss Intron A/Rebetol NDA

April 15, 1998

FDA approves fifth indication for Neupogen

April 14, 1998

Orphan Medical receives approval to market Sucraid in U.S.

April 14, 1998

Expanded indication approved for Proscar

April 8, 1998

FDA approves Actonel for Paget's disease

April 3, 1998

FDA clears pravastatin for stroke prevention

March 31, 1998

FDA approves Viagra; first oral treatment for ED on the way to market

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.